CYCLOSPORINE/CHONDROITIN PF- cyclosporine/chondroitin sulfate pf emulsion

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

CYCLOSPORINE (UNII: 83HN0GTJ6D) (CYCLOSPORINE - UNII:83HN0GTJ6D)

Disponible depuis:

Imprimis NJOF, LLC

Mode d'administration:

OPHTHALMIC

Type d'ordonnance:

PRESCRIPTION DRUG

Statut de autorisation:

unapproved drug other

Résumé des caractéristiques du produit

CYCLOSPORINE/CHONDROITIN PF- CYCLOSPORINE/CHONDROITIN SULFATE PF
EMULSION
IMPRIMIS NJOF, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
STORE AT 20° TO 25° C (68° TO 77° F)
CYCLOSPORINE/CHONDROITIN PF
cyclosporine/chondroitin sulfate pf emulsion
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:7138 4-514
ROUTE OF ADMINISTRATION
OPHTHALMIC
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
CYCLO SPO RINE (UNII: 8 3HN0 GTJ6 D) (CYCLOSPORINE - UNII:8 3HN0 GTJ6
D)
CYCLOSPORINE
1 mg in 1 mL
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:7138 4-514-
0 5
5.5 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n
Pro duc t
0 7/0 1/20 18
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 7/0 1/20 18
Imprimis NJOF, LLC
LABELER -
Imprimis NJOF, LLC (080431967)
Revised: 2/2020